The Immune Response Corporation
Patent Owner
Stats
- 3 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Dec 01, 2005 most recent publication
Details
- 3 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 749 Total Citation Count
- Mar 14, 1990 Earliest Filing
- 40 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
6328976 Non-infectious, protease defective HIV particles and nucleic acid molecules encoding thereforApr 03, 98Dec 11, 01[A61K]
5744326 Use of viral CIS-acting post-transcriptional regulatory sequences to increase expression of intronless genes containing near-consensus splice sitesMar 11, 96Apr 28, 98[C07H, C12N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2005/0266,015 Enhanced activity of HIV vaccine using a second generation immunomodulatory oligonucleotideAbandonedMar 11, 05Dec 01, 05[A61K]
2003/0108,517 Membrane-bound cytokine compositions and methods of modulating an immune response using sameAbandonedAug 19, 02Jun 12, 03[A61K]
6557296 Non-infectious, protease defective HIV particles and nucleic acid molecules encoding thereforExpiredJul 30, 01May 06, 03[C07H, A61K, C12Q, C12N]
2003/0072,751 IDIOTYPIC VACCINATION AGAINST B CELL LYMPHOMAAbandonedMar 14, 90Apr 17, 03[A61K, A01N, C12N]
2003/0044,428 Method for treating an HIV-infected individual by combining immunization with structured interruption of anti-retroviral treatmentAbandonedJan 24, 02Mar 06, 03[A61K]
6482407 Membrane-bound cytokine compositions comprising GM-CSF or an active fragment thereof and methods of modulating and an immune response using the sameExpiredMay 01, 01Nov 19, 02[A61K]
6464978 Vaccination and methods against multiple sclerosis resulting from pathogenic responses by specific T cell populationsExpiredApr 29, 93Oct 15, 02[A61K]
6221352 Method of preventing the proliferation of V.beta.14 or V.beta.17-Expressing T cellsExpiredJun 06, 95Apr 24, 01[A61K, C07K]
6207645 Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populationsExpiredJul 18, 94Mar 27, 01[A61K]
6159470 Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populationsExpiredJun 05, 95Dec 12, 00[A61K]
6090387 Vaccination and methods against diseases resulting from pathogenic responsesExpiredJun 06, 95Jul 18, 00[C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.